Correlation Between DXC Technology and AIM ImmunoTech

Can any of the company-specific risk be diversified away by investing in both DXC Technology and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DXC Technology and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DXC Technology Co and AIM ImmunoTech, you can compare the effects of market volatilities on DXC Technology and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DXC Technology with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of DXC Technology and AIM ImmunoTech.

Diversification Opportunities for DXC Technology and AIM ImmunoTech

-0.02

Correlation Coefficient

DXC Technology  AIM ImmunoTech

Good diversification

The 3 months correlation between DXC and AIM is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding DXC Technology Co and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and DXC Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DXC Technology Co are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of DXC Technology i.e., DXC Technology and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between DXC Technology and AIM ImmunoTech

Assuming the 90 days trading horizon DXC Technology Co is expected to under-perform the AIM ImmunoTech. But the stock apears to be less risky and, when comparing its historical volatility, DXC Technology Co is 3.2 times less risky than AIM ImmunoTech. The stock trades about -0.08 of its potential returns per unit of risk. The AIM ImmunoTech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  20.00  in AIM ImmunoTech on October 22, 2024 and sell it today you would earn a total of  0.00  from holding AIM ImmunoTech or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

DXC Technology Co  vs.  AIM ImmunoTech

DXC Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DXC Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, DXC Technology is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

AIM ImmunoTech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with DXC Technology and AIM ImmunoTech

The main advantage of trading using opposite DXC Technology and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DXC Technology position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.

The idea behind DXC Technology Co and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.